Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides

Int J Mol Sci. 2020 Mar 22;21(6):2197. doi: 10.3390/ijms21062197.

Abstract

Cell-penetrating peptides might have great potential for enhancing the therapeutic effect of drug molecules against such dangerous pathogens as Mycobacterium tuberculosis (Mtb), which causes a major health problem worldwide. A set of cationic cell-penetration peptides with various hydrophobicity were selected and synthesized as drug carrier of isoniazid (INH), a first-line antibacterial agent against tuberculosis. Molecular interactions between the peptides and their INH-conjugates with cell-membrane-forming lipid layers composed of DPPC and mycolic acid (a characteristic component of Mtb cell wall) were evaluated, using the Langmuir balance technique. Secondary structure of the INH conjugates was analyzed and compared to that of the native peptides by circular dichroism spectroscopic experiments performed in aqueous and membrane mimetic environment. A correlation was found between the conjugation induced conformational and membrane affinity changes of the INH-peptide conjugates. The degree and mode of interaction were also characterized by AFM imaging of penetrated lipid layers. In vitro biological evaluation was performed with Penetratin and Transportan conjugates. Results showed similar internalization rate into EBC-1 human squamous cell carcinoma, but markedly different subcellular localization and activity on intracellular Mtb.

Keywords: Langmuir monolayer; atomic force microscopy; cell-penetrating peptides; circular dichroism spectroscopy; drug–peptide conjugates; membrane affinity; mycolic acid.

MeSH terms

  • Amino Acid Sequence
  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacokinetics
  • Cell Line, Tumor
  • Cell-Penetrating Peptides / chemistry
  • Cell-Penetrating Peptides / metabolism*
  • Drug Carriers / chemistry
  • Drug Carriers / metabolism*
  • Humans
  • Isoniazid / administration & dosage*
  • Isoniazid / chemistry
  • Isoniazid / pharmacokinetics
  • Lipid Bilayers / metabolism
  • Membrane Lipids / metabolism*
  • Mycobacterium tuberculosis / drug effects
  • Tuberculosis / drug therapy

Substances

  • Antitubercular Agents
  • Cell-Penetrating Peptides
  • Drug Carriers
  • Lipid Bilayers
  • Membrane Lipids
  • Isoniazid